The Transcription Factor Sp3 Regulates the Expression of a Metastasis-Related Marker of Sarcoma, Actin Filament-Associated Protein 1-Like 1 (AFAP1L1)

PLoS ONE

Volumn 8, Issue 1, 2013, Pages

  Kajita, Yoichiro ^a,b   Kato, Tomohisa ^a   Tamaki, Sakura ^a   Furu, Moritoshi ^a,b   Takahashi, Ryo ^b   Nagayama, Satoshi ^b,e   Aoyama, Tomoki ^a   Nishiyama, Hiroyuki ^b,f   Nakamura, Eijiro ^b   Katagiri, Toyomasa ^c,g   Nakamura, Yusuke ^c   Ogawa, Osamu ^b   Toguchida, Junya ^a,b,d  

^a KYOTO UNIVERSITY   (Japan)

^b KYOTO UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^c THE UNIVERSITY OF TOKYO   (Japan)

^d KYOTO UNIVERSITY   (Japan)

^e CANCER INSTITUTE HOSPITAL   (Japan)

^f UNIVERSITY OF TOKUSHIMA   (Japan)

^g UNIVERSITY OF TSUKUBA   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ACTIN FILAMENT ASSOCIATED PROTEIN 1 LIKE 1; MITHRAMYCIN; SMALL INTERFERING RNA; TRANSCRIPTION FACTOR SP1; TRANSCRIPTION FACTOR SP3; TUMOR MARKER; UNCLASSIFIED DRUG;

AFAP1L1 GENE; ARTICLE; CANCER RISK; CHROMATIN IMMUNOPRECIPITATION; CONTROLLED STUDY; DISTANT METASTASIS; ENZYME INHIBITION; GENE; GENE ACTIVITY; GENE CONSTRUCT; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENE SILENCING; HUMAN; HUMAN CELL; IN VITRO STUDY; METASTASIS; NONHUMAN; PROMOTER REGION; PROTEIN BINDING; PROTEIN FUNCTION; PROTEIN STRUCTURE; RISK FACTOR; SARCOMA; SARCOMA CELL; SPINDLE CELL SARCOMA; TRANSACTIVATION; TRANSCRIPTION INITIATION SITE; UPREGULATION;

EID: 84872172640     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0049709     Document Type: Article

References (27)

1. Furu M, Kajita Y, Nagayama S, Ishibe T, Shima Y, et al. (2011) Identification of AFAP1L1 as a prognostic marker for spindle cell sarcomas. Oncogene 30: 4015-4025.
2. Kawai A, Naito N, Yoshida A, Morimoto Y, Ouchida M, et al. (2004) Establishment and characterization of a biphasic synovial sarcoma cell line, SYO-1. Cancer Lett 204: 105-113.
3. Kato T Jr, Gotoh Y, Hoffmann A, Ono Y, (2008) Negative regulation of constitutive NF-κB and JNK signaling by PKN1-mediated phosphorylation of TRAF1: Genes to Cells. 13: 509-520.
4. Kohno Y, Okaκmoto T, Ishibe T, Nagayama S, Shima Y, et al. (2006) Expression of claudin7 is tightly associated with epithelial structures in synovial sarcomas and regulated by an Ets family transcription factor, ELF3. J Biol Chem 281: 38941-38950.
5. Sapetschnig A, Koch F, Rischitor G, Mennenga T, Suske G, (2004) Complexity of translationally controlled transcription factor Sp3 isoform expression. J Biol Chem 279: 42095-42105.
6. Aoyama T, Okamoto T, Kohno Y, Fukiage K, Otsuka S, et al. (2008) Cell-specific epigenetic regulation of ChM-I gene expression: crosstalk between DNA methylation and histone acetylation. Biochem Biophys Res Commun 365: 124-130.
7. Sandelin A, Wasserman WW, Lenhard B, (2004) ConSite: web-based prediction of regulatory elements using cross-species comparison. Nucleic Acids Res 32: W249-252.
8. Giatzakis C, Batarseh A, Dettin L, Papadopoulos V, (2007) The role of Ets transcription factors in the basal transcription of the translocator protein (18 kDa). Biochemistry 46: 4763-4774.
9. Shirasaki F, Makhluf HA, LeRoy C, Watson DK, Trojanowska M, (1999) Ets transcription factors cooperate with Sp1 to activate the human tenascin-C promoter. Oncogene 18: 7755-7764.
10. Blume SW, Snyder RC, Ray R, Thomas S, Koller CA, et al. (1991) Mithramycin inhibits SP1 binding and selectively inhibits transcriptional activity of the dihydrofolate reductase gene in vitro and in vivo. J Clin Invest 88: 1613-1621.
11. Ray R, Snyder RC, Thomas S, Koller CA, Miller DM, (1989) Mithramycin blocks protein binding and function of the SV40 early promoter. J Clin Invest 83: 2003-2007.
12. Xu J, Bai XH, Lodyga M, Han B, Xiao H, et al. (2007) XB130, a novel adaptor protein for signal transduction. J Biol Chem 282: 16401-16412.
13. Flynn DC, Leu TH, Reynolds AB, Parsons JT, (1993) Identification and sequence analysis of cDNAs encoding a 110-kilodalton actin filament-associated pp60src substrate. Mol Cell Biol 13: 7892-7900.
14. Lodyga M, De Falco V, Bai XH, Kapus A, Melillo RM, et al. (2009) XB130, a tissue-specific adaptor protein that couples the RET/PTC oncogenic kinase to PI 3-kinase pathway. Oncogene 28: 937-949.
15. Snyder BN, Cho Y, Qian Y, Coad JE, Flynn DC, et al. (2011) AFAP1L1 is a novel adaptor protein of the AFAP family that interacts with cortactin and localizes to invadosomes. Eur J Cell Biol 90: 376-389.
16. Suske G, (1999) The Sp-family of transcription factors. Gene 238: 291-300.
17. Kadonaga JT, Carner KR, Masiarz FR, Tjian R, (1987) Isolation of cDNA encoding transcription factor Sp1 and functional analysis of the DNA binding domain. Cell 51: 1079-1090.
18. Yu B, Datta PK, Bagchi S, (2003) Stability of the Sp3-DNA is promoter-specific: Sp3 efficiently competes with Sp1 for binding to promoters containing multiple Sp-sites. Nucleic Acids Res 31: 5368-5376.
19. Safe S, Abdelrahim M, (2005) Sp transcription factor family and its role in cancer. Eur J Cancer 41: 2438-2448.
20. Wang L, Wei D, Huang S, Peng Z, Le X, et al. (2003) Transcription factor Sp1 expression is a significant predictor of survival in human gastric cancer. Clin Cancer Res 9: 6371-6380.
21. Chiefari E, Brunetti A, Arturi F, Bidart JM, Russo D, et al. (2002) Increased expression of AP2 and Sp1 transcription factors in human thyroid tumors: a role in NIS expression regulation? BMC Cancer 2: 35.
22. Hosoi Y, Watanabe T, Nakagawa K, Matsumoto Y, Enomoto A, et al. (2004) Up-regulation of DNA-dependent protein kinase activity and Sp1 in colorectal cancer. Int J Oncol 25: 461-468.
23. Abdelrahim M, Smith R 3rd, Burghardt R, Safe S, (2004) Role of Sp proteins in regulation of vascular endothelial growth factor expression and proliferation of pancreatic cancer cells. Cancer Res 64: 6740-6749.
24. Wright C, Angus B, Napier J, Wetherall M, Udagawa Y, et al. (1987) Prognostic factors in breast cancer: immunohistochemical staining for SP1 and NCRC 11 related to survival, tumour epidermal growth factor receptor and oestrogen receptor status. J Pathol 153: 325-331.
25. Essafi-Benkhadir K, Grosso S, Puissant A, Robert G, Essafi M, et al. (2009) Dual role of Sp3 transcription factor as an inducer of apoptosis and a marker of tumour aggressiveness. PLoS One 4: e4478.
26. Barretina J, Taylor BS, Banerji S, Ramos AH, Lagos-Quintana M, et al. (2010) Subtype-specific genomic alterations define new targets for soft-tissue sarcoma therapy. Nat Genet 42: 715-721.
27. Detwiller KY, Fernando NT, Segal NH, Ryeom SW, D'Amore PA, et al. (2005) Analysis of hypoxia-related gene expression in sarcomas and effect of hypoxia on RNA interference of vascular endothelial cell growth factor A. Cancer Res 65: 5881-5889.